You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.

21 December 2016

Experimental PrEP drug injected once every two months to begin global trial

Adherence challenges with pre-exposure prophylaxis (PrEP) could be overcome if experimental long-acting HIV drug is found to be effective and acceptable.

0
25 November 2016

Treatment access masks wider barriers to 2020 targets

Treatment access gains are to be applauded – but we will get nowhere if we don’t prevent more new infections and reach out to key affected populations.

0
23 November 2016

Global ‘War on Drugs’ has failed and exacerbated the HIV epidemic, say global experts

Drug policy based on prohibition hasn't worked. It's time to build on the success of partial-decriminalisation models with an emphasis on health and human rights, says new report.

0
18 November 2016

Harm reduction programmes: ‘too few, too vulnerable and too underfunded’

People who inject drugs are increasingly left behind in the HIV response, with limited access to harm reduction services that secure their rights and their health. 

0
26 April 2016

Civil society left disappointed by UNGASS on drugs

Negotiating the political minefield of global drug policy has left civil society and many progressive-thinking countries disappointed by the outcomes of last week’s United Nations General Assembly Special Session (UNGASS) on the World Drug Problem, and frustrated by the UNGASS process.

0
05 February 2016

Analysis: Tenofovir resistance ‘surprisingly common’

Resistance to the commonly prescribed antiretroviral drug tenofovir is ‘surprisingly common’, according to findings published in the Lancet Infectious Diseases last week. 

0